Insulet (PODD) Enterprise Value (2010 - 2026)
Insulet (PODD) posted Enterprise Value of -$480.4 million for Q1 2026, up 32.91% on a QoQ basis from -$716.1 million in Q4 2025, and up 62.56% year-over-year from -$295.5 million in Q1 2025.
Insulet (PODD) Enterprise Value (2010 - 2026) Analysis & Trends
Insulet's Enterprise Value history runs 17 years deep, the most recent figure standing at -$480.4 million for Q1 2026.
- Quarterly Enterprise Value rose 62.56% year-over-year to -$480.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$480.4 million (up 62.56% YoY) and the FY2025 annual result came in at -$716.1 million, up 24.89% from the prior year.
- Enterprise Value was -$480.4 million for Q1 2026 at Insulet, up from -$716.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$480.4 million in Q1 2026 and bottomed at -$1.3 billion in Q1 2025.
- A 5-year average of -$782.7 million and a median of -$716.1 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value sank 70.81% — and 2026, when it surged 62.56%.
- Insulet's Enterprise Value stood at -$675.2 million in 2022, then dropped by 4.3% to -$704.2 million in 2023, then slumped by 35.39% to -$953.4 million in 2024, then advanced by 24.89% to -$716.1 million in 2025, then surged by 32.91% to -$480.4 million in 2026.
- Business Quant data shows PODD's Enterprise Value at -$480.4 million in Q1 2026, -$716.1 million in Q4 2025, and -$757.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -3.09 Bn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | -480.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -480.40 Mn |
| Dec 31, 2025 | -716.10 Mn |
| Sep 30, 2025 | -757.40 Mn |
| Jun 30, 2025 | -1.12 Bn |
| Mar 31, 2025 | -1.28 Bn |
| Dec 31, 2024 | -953.40 Mn |
| Sep 30, 2024 | -902.60 Mn |
| Jun 30, 2024 | -821.00 Mn |
| Mar 31, 2024 | -751.20 Mn |
| Dec 31, 2023 | -704.20 Mn |
| Sep 30, 2023 | -701.00 Mn |
| Jun 30, 2023 | -675.50 Mn |
| Mar 31, 2023 | -620.70 Mn |
| Dec 31, 2022 | -675.20 Mn |
| Sep 30, 2022 | -722.50 Mn |
| Jun 30, 2022 | -709.80 Mn |
| Mar 31, 2022 | -710.70 Mn |
| Dec 31, 2021 | -793.20 Mn |
| Sep 30, 2021 | -857.10 Mn |
| Jun 30, 2021 | -872.10 Mn |